Clinical trial
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
NCT00222807 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00222807 |
|---|---|
| Title | Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus |
| Official title | Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | American Association for Geriatric Psychiatry Janssen Pharmaceuticals Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Schizophrenia, Schizoaffective Disorder, Delusional Disorder |
| Enrollment | 200 |
| Start date | Aug 1, 2003 |
| Primary completion | Mar 1, 2016 |
| Completion | Mar 1, 2016 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: